APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types

Cited by (215)

Items 101–200 of 215

  1. Contributions of Genetic Variation in Astrocytes to Cell and Molecular Mechanisms of Risk and Resilience to Late‐Onset Alzheimer's Disease
    Hyo Lee, Richard V. Pearse, Alexandra M Lish, Cheryl Pan, Zachary M. Augur, Gizem Terzioğlu, Pallavi Gaur, Meichen Liao, Masashi Fujita, Earvin S. Tio et al. · 2025 · Glia
  2. Efficient derivation of excitatory and inhibitory neurons from human pluripotent stem cells stably expressing direct reprogramming factors
    Saera Song, A. Ashok, Damian J. Williams, Maria E. Kaufman, K. Duff, Andrew A. Sproul · 2021 · Current Protocols
  3. Sex and APOE Genotype Alter the Basal and Induced Inflammatory States of Primary Astrocytes from Humanized Targeted Replacement Mice
    Isha Mhatre‐Winters, Aseel Eid, Yoonhee Han, Kim Tieu, Jason R. Richardson · 2023 · ASN NEURO
  4. The APOE isoforms differentially shape the transcriptomic and epigenomic landscapes of human microglia xenografted into a mouse model of Alzheimer's disease
    Murphy, Kitty B., Hu, Di, Wolfs, Leen, Rohde, Susan K., Fauró, Gonzalo Leguía, Geric, Ivana, Mancuso, Renzo, De Strooper, Bart, Marzi, Sarah J. · 2025 · Nature Communications
  5. Exploring mitochondrial cholesterol signalling for therapeutic intervention in neurological conditions
    Radha Desai, Michelangelo Campanella · 2019 · British Journal of Pharmacology
  6. Nutrition in Alzheimer’s disease: a review of an underappreciated pathophysiological mechanism
    Jiwei Jiang, Hanping Shi, Shirui Jiang, Anxin Wang, Xinying Zou, Yanli Wang, Wenyi Li, Yuan Zhang, Mengfan Sun, Qiwei Ren et al. · 2023 · Science China Life Sciences
  7. FunSPU: A versatile and adaptive multiple functional annotation-based association test of whole-genome sequencing data
    Yiding Ma, Peng Wei · 2019 · PLoS Genetics
  8. Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk
    David P. Bradley · 2020 · Biomarker Insights
  9. Loss of endosomal exchanger NHE6 leads to pathological changes in tau in human neurons
    Marty A. Fernandez, Fatmata Bah, Li Ma, Youjin Lee, Michael Schmidt, Elizabeth Welch, Eric M. Morrow, Tracy L. Young‐Pearse · 2022 · Stem Cell Reports
  10. Brain and Retinal Organoids for Disease Modeling: The Importance of In Vitro Blood–Brain and Retinal Barriers Studies
    Ilenia Martinelli, Seyed Khosrow Tayebati, Daniele Tomassoni, Giulio Nittari, Proshanta Roy, Francesco Amenta · 2022 · Cells
  11. APOE4 genotype and aging impair injury-induced microglial behavior in brain slices, including toward Aβ, through P2RY12
    Jordy Sepulveda, Jennifer Yejean Kim, Joseph Binder, Stefano Vicini, George William Rebeck · 2024 · Molecular Neurodegeneration
  12. Brain organoid model systems of neurodegenerative diseases: recent progress and future prospects
    Saniyah Shaikh, Luqman Siddique, Hafsah Tajammul Khalifey, Rutaba Mahereen, Thaabit Raziq, Rushdan Mohamed Firdous, Aisha Siddique, Ismail Mohammed Shakir, Zara Ahmed, Arshiya Akbar et al. · 2025 · Frontiers in Neuroscience
  13. Astrocyte Lipid Droplet Dynamics Orchestrate Neurological Disorders and Therapeutic Horizons
    Jiani Zhong, Yanyi Peng, Lingyue Zhang, Bo Xiao, Mengqi Zhang · 2025 · Small Science
  14. An insight into the iPSCs-derived two-dimensional culture and three-dimensional organoid models for neurodegenerative disorders
    Anushka Bhargava, Ana Maria Sandoval-Castellanos, Sonali S. Shah, Ke Ning · 2022 · Interface Focus
  15. ApoE4 Astrocytes Secrete Basement Membranes Rich in Fibronectin and Poor in Laminin Compared to ApoE3 Astrocytes
    Keable, Abby, O’Neill, Ronan, MacGregor Sharp, Matthew, Gatherer, Maureen, Yuen, Ho Ming, Johnston, David Annandale, Weller, Roy Oliver, Carare, Roxana Octavia · 2020 · International Journal of Molecular Sciences
  16. Excessive/Aberrant and Maladaptive Synaptic Plasticity: A Hypothesis for the Pathogenesis of Alzheimer’s Disease
    Kawabata, Shigeki · 2022 · Frontiers in Aging Neuroscience
  17. APOE-Targeted Therapeutics for Alzheimer's Disease
    Yassine, Hussein N., Hugo, Cristelle, O'Donovan, Bernadette, Stephens, Isaiah O., Johnson, Lance A., Cole, Gregory, TCW, Julia, Johansson, Jan, Kisler, Kassandra, Chiba-Falek, Ornit · 2025 · The Journal of Neuroscience
  18. Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders
    S Rehan Ahmad, Md. Zeyaullah, Abdullah M. AlShahrani, Adam Dawria, Haroon Ali, Ali Mohieldin, Abdelrhman A. G. Altijani, Ufaq Razi, Munzila Mehdi, Sabika Akram et al. · 2024 · Frontiers in Bioscience-Landmark
  19. Pluripotent stem cells for neurodegenerative disease modeling: an expert view on their value to drug discovery
    Shi-Dong Chen, Hong‐Qi Li, Mei Cui, Qiang Dong, Jin‐Tai Yu · 2020 · Expert Opinion on Drug Discovery
  20. Multiscale Analysis of Cellular Composition and Morphology in Intact Cerebral Organoids
    Haihua Ma, Juan Chen, Zhiyu Deng, Tingting Sun, Qingming Luo, Hui Gong, Xiangning Li, Ben Long · 2022 · Biology
  21. Modeling neurodegenerative diseases with brain organoids: from development to disease applications
    Teresa Larriba-González, Marina García-Martín, Doddy Denise Ojeda-Hernández, Paula Rincón-Cerrada, Lucía Martín-Blanco, María Soledad Benito‐Martín, Belén Selma-Calvo, Sarah de la Fuente-Martín, Jordi A. Matías‐Guiu, Jorge Matías‐Guiu et al. · 2025 · Frontiers in Cell and Developmental Biology
  22. Animal Model Alternatives in Filovirus and Bornavirus Research
    Lina Widerspick, Johanna Friederike Steffen, Dennis Tappe, César Muñoz‐Fontela · 2023 · Viruses
  23. Insights for disease modeling from single-cell transcriptomics of iPSC-derived Ngn2-induced neurons and astrocytes across differentiation time and co-culture
    D Das, Shreyash Sonthalia, G. Stein-O.’Brien, MH. Wahbeh, Kyra L. Feuer, Loyal A. Goff, Carlo Colantuoni, Vasiliki Mahairaki, Dimitrios Avramopoulos · 2024 · BMC Biology
  24. Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse model
    Bert M. Verheijen, Jo Stevens, Romina J. G. Gentier, Christian D. van ‘t Hekke, Daniël van den Hove, Denise J. H. P. Hermes, Harry W.M. Steinbusch, Jan M. Ruijter, Marcus O.W. Grimm, Viola J. Haupenthal et al. · 2018 · Neurobiology of Aging
  25. CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment
    Siddhant Tripathi, Yashika Sharma, Rajesh A. Rane, Dileep Kumar · 2024 · CNS & Neurological Disorders - Drug Targets
  26. Successful Gene Editing of Apolipoprotein E4 to E3 in Brain of Alzheimer Model Mice After a Single IV Dose of Synthetic Exosome-Delivered CRISPR
    Bruce Teter, Jesus J. Campagna, Chunni Zhu, Grace E. McAuley, Patricia R. Spilman, Donald B. Kohn, Varghese John · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  27. A single cell brain atlas in human Alzheimer’s disease
    Alexandra Grubman, Gabriel Chew, John F. Ouyang, Guizhi Sun, Xin Yi Choo, Catriona McLean, Rebecca K. Simmons, Sam Buckberry, Dulce B. Vargas-Landín, Jahnvi Pflueger et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  28. ABCA7 Loss-of-Function Variants Impact Phosphatidylcholine Metabolism in the Human Brain
    Djuna Katrina von Maydell, Shannon Wright, Ping‐Chieh Pao, Colin Staab, Oisín King, Andrea Spitaleri, Julia Maeve Bonner, Liwang Liu, Chung Jong Yu, Ching-Chi Chiu et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  29. β-Amyloid species production and tau phosphorylation in iPSC-neurons with reference to neuropathologically characterized matched donor brains
    Derek H. Oakley, Mirra Chung, Sara Abrha, Bradley T. Hyman, Matthew P. Frosch · 2024 · Journal of Neuropathology & Experimental Neurology
  30. Nogo‑66 promotes β‑amyloid protein secretion via NgR/ROCK‑dependent BACE1 activation
    Qingqing Xie, Xiao Ming Feng, Yi-Υun Huang, Nian Fang, Hua Yi, Zi-Jian Wang, Qiao-Υu Cao, Guofeng Lou, Junping Pan, Yang Hu et al. · 2021 · Molecular Medicine Reports
  31. Changes in iPSC-astrocyte morphology reflect Alzheimer’s disease patient clinical markers
    Helen A Rowland, Georgina Miller, Qiang Liu, Shuhan Li, Nicola R Sharp, Bryan Ng, Liting Wei, Kanisa Arunasalam, Ivan G. Koychev, Anne Hedegaard et al. · 2024 · Stem Cells
  32. Human iPSC-derived cerebral organoids reveal oxytocin-mediated protection against amyloid-β pathology
    Tomoki Asaba, Sayuri Hamano, Ayaka Nanmo, Jieun Seo, Tatsuto Kageyama, Junji Fukuda · 2025 · Regenerative Therapy
  33. Human iPSC‐Derived Microglia Integrate Into Cerebral Organoids and Assume an In Vivo‐Like Phenotype
    Emile Wogram, Felix Sümpelmann, Andrew S. Khalil, Anthony Flamier, Dongdong Fu, George W. Bell, Rudolf Jaenisch · 2025 · European Journal of Neuroscience
  34. Mercury Ion Binding to Apolipoprotein E Variants ApoE2, ApoE3, and ApoE4: Similar Binding Affinities but Different Structure Induction Effects
    Elina Berntsson, Merlin Friedemann, Andra Noormägi, Jüri Jarvet, Per M. Roos, Vello Tõugu, Astrid Gräslund, Peep Palumaa, Sebastian K.T.S. Wärmländer · 2022 · ACS Omega
  35. Identification of a BACE1 Binding Peptide Candidate for the Prevention of Amyloid Beta in Alzheimer’s Disease
    Justin L. Read, Cenk Suphioglu · 2019 · Cellular Physiology and Biochemistry
  36. Nanotechnology-based delivery for CRISPR-Cas 9 cargo in Alzheimer's disease
    Shruti U. Rawal, Akruti Khodakiya, Bhupendra Gopalbhai Prajapati · 2024 · Elsevier eBooks
  37. Proteomic and metabolic profiling reveals APOE4 -dependent shifts in whole brain, neuronal, and astrocytic mitochondrial function and glycolysis
    Colton R Lysaker, Chelsea N. Johnson, Vivien Csikós, Edziu Franczak, Maggie N. Benson, Caleb A. Gilmore, Cole J. Birky, Xin C. Davis, Colin S. McCoin, Keith P. Smith et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Robust Tissue Fabrication for Long-Term Culture of iPSC-Derived Brain Organoids for Aging Research
    Lena Sophie Koch, David Choy Buentello, Kerensa Broersen · 2023 · Journal of Visualized Experiments
  39. PILRA regulates microglial neuroinflammation and lipid metabolism as a candidate therapeutic target for Alzheimer’s disease
    Kathryn M. Monroe, Tanya N. Weerakkody, Hanna Sabelström, David Tatarakis, Jung H. Suh, Marcus Y. Chin, Shan V. Andrews, Nicholas E. Propson, Srijana Balasundar, Sonnet S. Davis et al. · 2024 · Research Square
  40. Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD
    Shaowei Wang, Boyang Li, Zhiheng Cai, Cristelle Hugo, Jie Li, Yi Eve Sun, Qian Lü, Alan Thomas Remaley, Julia TCW, Helena Chang Chui et al. · 2024 · Research Square
  41. Organelle perturbation in Alzheimer’s disease: do intracellular amyloid-ß and the fragmented Golgi mediate early intracellular neurotoxicity?
    Lou Fourrière, Paul A. Gleeson · 2025 · Frontiers in Cell and Developmental Biology
  42. Apolipoprotein E4 and synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic implications
    Zhiying Yao, Ivan Steve Godje Godje, Bin Jiao, Lu Shen, Shilin Luo · 2026 · Ageing Research Reviews
  43. Targeting apolipoprotein E for treating Alzheimer’s disease
    Kelly R. Bales, Steven M. Paul · 2019 · Neuroscience Letters
  44. A review of CRISPR Cas9 for ASCVD: treatment strategies and could target PSCK9 gene using CRISPR cas9 prevent the patient from atherosclerotic vascular disease?
    Bambang Edi Suwito, Arga Setyo Adji, Vira Aulia Kusuma Wardani, Jordan Steven Widjaja, Syalomitha Claudia Stefanie Angel, Firman Suryadi Rahman · 2022 · Bali Medical Journal
  45. An Integrated Multi-omics Approach Identifies Therapeutic Potential for ATP6V1A in Late Onset Alzheimer’s Disease
    China N. Byrns, Nancy M. Bonini · 2021 · Neuron
  46. Overview of the Molecular Modalities and Signaling Pathways Intersecting with β-Amyloid and Tau Protein in Alzheimer’s Disease
    Ahmed M. Elshazly, Melanie M. Sinanian, Diaaeldin M. Elimam, Sherin Zakaria · 2023 · Neuroglia
  47. RETRACTED: Modeling Brain Somatic Mosaicism With Cerebral Organoids, Including a Note on Mutant Microglia
    Bert M. Verheijen · 2019 · Frontiers in Molecular Neuroscience · Retracted
  48. Lipid metabolism in Alzheimer’s disease
    Jienian Zhang, Jian Sima · 2024 · Aging Research
  49. hiPSC-based models to decipher the contribution of human astrocytes to Alzheimer’s disease and potential therapeutics
    Julia TCW, Amaia M. Arranz · 2023 · Molecular Neurodegeneration
  50. CRISPR/Cas9 gene editing: A new hope for Alzheimer's disease
    Gadde Shareena, Viswapriya Viswalingam, Mithun Singh Rajput, Dileep Kumar · 2024 · Elsevier eBooks
  51. Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies
    Siddhant Tripathi, Yashika Sharma, Dileep Kumar · 2024 · Current Protein and Peptide Science
  52. Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
    Andrew Nathanael Shen, Katelin S. Matazel, W. Drew Gill, Lorna C. Ewart, Randy S. Daughters, Héctor Rosas-Hernández · 2026 · Fluids and Barriers of the CNS
  53. Recapitulation and investigation of human brain development with neural organoids
    Atsushi Tamada, Keiko Muguruma · 2023 · IBRO Neuroscience Reports
  54. Human induced pluripotent stem cell models for Alzheimer’s disease research: a bibliometric analysis
    Yuning Sun, Zhilong Liu, Zongbo Zhang, Yufeng Kang, Xinjiang Wang, Yiping Zhang, Yanru Liu, Pei Zhao · 2025 · Frontiers in Human Neuroscience
  55. The Impact of Apolipoprotein E Allelic Variants on Alzheimer’s Disease
    Ezequiel Serrano, Pablo G. Sanz, Francisco José Barrantes · 2021 · Springer eBooks
  56. An amino-terminal fragment of apolipoprotein E4 leads to behavioral deficits, increased PHF-1 immunoreactivity, and mortality in zebrafish
    Madyson M. McCarthy, Makenna J. Hardy, Saylor E. Leising, Alex M. LaFollette, Erica S. Stewart, Amelia S. Cogan, Tanya Sanghal, Katie Matteo, Jonathon C. Reeck, Julia Thom Oxford et al. · 2022 · PLoS ONE
  57. Induced pluripotent stem cell technology: venturing into the second decade
    Yanhong Shi, Haruhisa Inoue, Jun B. Takahashi, Shinya Yamanaka · 2020 · Elsevier eBooks
  58. Human 8-cell embryos enable efficient induction of disease-preventive mutations without off-target effect by cytosine base editor
    Yinghui Wei, Meiling Zhang, Jing Tao Hu, Yingsi Zhou, Mingxing Xue, Jianhang Yin, Yuanhua Liu, Hu Feng, Ling Zhou, Zhifang Li et al. · 2022 · Protein & Cell
  59. Applications of Induced Pluripotent Stem Cell-Derived Glia in Brain Disease Research and Treatment
    Zhiqi Yang, Mingyue Gong, Chuanyan Yang, Chunhai Chen, Kuan Zhang · 2023 · Handbook of experimental pharmacology
  60. Generating Homogeneous Brain Organoids from Human iPSCs
    Xianwei Chen, Yanhong Shi · 2024 · Methods in molecular biology
  61. Human induced pluripotent stem cell– based modeling of Alzheimer’s disease, a glial perspective
    Xianwei Chen, Qingqiu Yang, Zhenqing Liu, Yanhong Shi · 2021 · Elsevier eBooks
  62. Modeling neurological disease using human stem cell-derived microglia-like cells transplanted into rodent brains
    Fadi Jacob, Mariko L. Bennett · 2020 · Lab Animal
  63. APOE ε3/ε4 and APOE ε4/ε4 genotypes drive unique gene signatures in the cortex of young mice
    Kate E. Foley, Dylan T. Garceau, Kevin P. Kotredes, Gregory W. Carter, Michael Sasner, Gareth R. Howell · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Early and lifelong effects of APOE4 on neuronal gene expression networks relevant to Alzheimer’s disease
    Brian P. Grone, Kelly A. Zalocusky, Yanxia Hao, Seo Yeon Yoon, Patrick Arriola, Yadong Huang · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  65. ApoE expression across the CNS: Who, What, Where, When, and How (much)?
    Nolt, Georgia L., Lucido, Chloe C., Smith, Lily M., Johnson, Lance A. · 2026 · Molecular Neurodegeneration Advances
  66. Drug Discovery in Induced Pluripotent Stem Cell Models
    Kyla Bourque, Nourhen Mnasri, Jace Jones-Tabah, Kimberly Martins-Cannavino, Terence E. Hébert · 2021 · Elsevier eBooks
  67. Astrocyte Autophagy in Neurodegenerative Diseases: Current Progress in Mechanisms and Therapeutics
    Jialei Qian, Shengyuan Ren, Tianning Ren, Renke Shi, Liang Qiao, Jing‐Qiong Kang · 2025 · Neurochemical Research
  68. Mitochondria and Lipids in Cellular Signaling of the Brain: from Physiology to Neurodegeneration
    Plamena R. Angelova, Lauren Elizabeth Millichap, Andrey Y. Abramov · 2026 · Molecular and Cellular Biology
  69. Stimulus-Based ApoE Alzheimer’s Disease Induction Model Using Microglia-Containing Brain Organoids for Drug Discovery
    Nina Y. Yuan, William D. Richards, Kailyn T. Parham, Sophia G. Clark, Connie S. Lebakken · 2026 · Cells
  70. hPSC-Derived Astrocytes at the Forefront of Translational Applications in Neurological Disorders
    Vukasin M. Jovanovic, Kendall T. Mesch, Carlos A. Tristan · 2024 · Cells
  71. A review of current developments in Alzheimer’s disease treatment methods
    Linfeng Xu · 2023 · Theoretical and Natural Science
  72. Astrocytes in Primary Familial Brain Calcification (PFBC): Emphasis on the Importance of Induced Pluripotent Stem Cell-Derived Human Astrocyte Models
    Ebru Kavakli, Nazli Gul, Onur Can Begentas, Erkan Kiris · 2025 · Advances in experimental medicine and biology
  73. Functional Validation of Alcohol Dependence-Associated FYN Variants Using Gene Editing and Stem Cell Study Approaches
    Bilal Çakır, Yoshiaki Tanaka, Mu Seog Choe, Pei-Yu Chu, Yangfei Xiang, Kun‐Yong Kim, Mei Zhong, Joel E. Gelernter, Huiping Zhang, John Harrison Krystal et al. · 2025 · International Journal of Stem Cells
  74. Testosterone as a mediator of APOE4-linked sex differences in Alzheimer's disease
    Zhidan Shi, Liang Wu, Chu Zhang, Xiaoqian Zeng, Guangzhe Yao, Xinqi He, Jiayi Hu, Tian Xie, Ling He · 2025 · International Immunopharmacology
  75. Disease-associated RNA and protein signatures in iPSC-derived microglia model of Alzheimer’s disease
    Wenzhe Wu, Eun Seok Choi, Luke Liu, Veena Thamilselvan, L LI, Meagan D. Rippee‐Brooks, Kashish Khatkar, Dar-Yin Li, Denise McGrath, Aidan C. Manning et al. · 2026 · Frontiers in Neuroscience
  76. APOE4-drives brain bioenergetic shifts independent of Alzheimer’s disease pathology
    Lysaker, Colton R., Johnson, Chelsea N., Csikos, Vivien, Franczak, Edziu, Benson, Maggie, Gilmore, Caleb A., Birky, Cole J., Davis, Xin, McCoin, Colin S., Smith, Keith P. et al. · 2026 · npj Dementia
  77. Pathology of different tau protein species in neurodegenerative diseases: Alzheimer’s disease, corticobasal degeneration, and progressive supranuclear palsy
    Mohammad Majidi, Aref Rajabi, Shamseddin Ahmadi · 2021 · Scientific Journal of Kurdistan University of Medical Sciences
  78. Recovery Profiles after Concussion among Male Student-Athletes and Service Cadets with a Family History of Neurodegenerative Disease: Data from the NCAA-DoD CARE Consortium
    Adam T. Harrison, Thomas W. McAllister, Michael McCrea, Steven P. Broglio, Robert Davis Moore, Scott A. Anderson, Holly J. Benjamin, Thomas A. Buckley, Sara P.D. Chisman, James R. Clugston et al. · 2020 · Journal of Neurotrauma
  79. Transcriptional landscape of human microglia reveals robust gene expression signatures that implicates age, sex and APOE-related immunometabolic pathway perturbations
    Tulsi Patel, Troy Carnwath, Xue Wang, Mariet Allen, Sarah Lincoln, Laura J. Lewis‐Tuffin, Zachary Quicksall, Shu Lin, Frederick Q Tutor‐New, Charlotte C.G. Ho et al. · 2021 · Research Square
  80. Engineered 3D Immuno-Glial-Neurovascular Human miBrain Model
    Li‐Huei Tsai, Alice E. Stanton, Adele Bubnys, Emre Agbas, Benjamin T. James, Dong Shin Park, Alan Y. L. Jiang, Rebecca L. Pinals, Liwang Liu, Nhat Truong et al. · 2024 · Research Square
  81. The APOE isoforms differentially shape the transcriptomic and epigenomic landscapes of human microglia in a xenotransplantation model of Alzheimer’s disease
    Kitty B. Murphy, Di Hu, Leen Wolfs, Renzo Mancuso, Bart De Strooper, Sarah J. Marzi · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Human induced pluripotent stem cell-derived microglia with a CX3CR1-V249I genetic variant exhibit dysfunctional phenotypes and modulate neuronal growth and function
    Kaylee D. Tutrow, Jade Harkin, L. Varghese, Melody Hernandez, Kang-Chieh Huang, Yue Fang, Parker Wilcox, Logan M. Bedford, Tsai‐Yu Lin, Chi Zhang et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  83. TLR4-Mediated Neuroinflammation in Human Induced Pluripotent Stem Cells and Cerebral Organoids
    Massimiliano De Paola · 2020 · Progress in inflammation research
  84. Characterization of microglial Rab7 knockout on amyloid pathology in the 5xFAD mouse model of Alzheimer’s disease
    Beate Maren Erika Koch · 2019 · eDiss (Georg-August-Universität Göttingen)
  85. CRISPR/Cas9 technologies to manipulate human induced pluripotent stem cells
    Hyunsoo Jang, Jihoon Moon, Namshik Kim, Ki‐Jun Yoon · 2021 · Elsevier eBooks
  86. Revisión bibliográfica de los avances más recientes en la comprensión etiológica de la enfermedad de Alzheimer
    Uziel Amit Téllez Ramírez, María Eugenia Medina, Ana Paulina Reyes Ruiz, María de los Ángeles Silva Borja, Oscar Uriel Díaz Ricoy · 2021 · Lux Médica
  87. New Prospects for Stem Cell Therapy in Alzheimer’s Disease
    Kun Jiang, Yongqi Zhu, Lei Zhang · 2021 · IntechOpen eBooks
  88. Neurotoxic astrocytes secreted glypican-4 drives Alzheimer’s tau pathology
    Ana C. Pereira, Sivaprakasam R. Saroja · 2020
  89. Modeling genetic risk factor of alzheimer’s disease “SORL1” using patient specific pluripotent stem cells
    Kamonchanok Kongsri · 2020
  90. Upregulated NF-κB pathway proteins may underlie APOE44 associated astrocyte phenotypes in sporadic Alzheimer’s disease
    Adele Pryce Roberts, Karolina Dec, Branduff McAllister, Victoria J. Tyrrell, Valerie B. O’Donnell, Adrian J. Harwood, Julie H. Williams · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  91. JoVE Video Dataset
    Lena Sophie Koch, David Choy Buentello, Kerensa Broersen · 2023
  92. iPSC-Astrocyte morphology reflects patient clinical markers
    Helen A. Rowland, Georgina Miller, Qiang Liu, Nicola R Sharp, Bryan Ng, Tina Wei, Kanisa Arunasalam, I. Koychev, A. Hedegaard, Elena M. Ribe et al. · 2023 · bioRxiv
  93. The ubiquitin-proteasome system in neurodegenerative diseases
    Lambertus Verheijen · 2023 · Research Publications (Maastricht University)
  94. Divergent Effects of APOE3 and APOE4 Human Astrocytes on Key Alzheimer’s Disease Hallmarks in Chimeric Mice
    Joan Cruz-Sesé, Marta Miron-Alcala, María Alfonso-Triguero, Jon Olalde, Leire Ruiz, Nuria Galbis-Gramage, Lorea Cortes, Laura Escobar, Pranav Preman, An Snellinx et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Neurodegenerative diseases as a target for genome editing: from preclinical studies to clinical practice
    Sergey Yu Tereshchenko, Tatyana Vitalyevna Potupchik, Lidia Semyonovna Evert, L.G. Alieva, Y.E. Kozyrina, A.A. Maremkulov · 2025 · Molekulyarnaya Meditsina (Molecular medicine)
  96. Taurine inhibits apolipoprotein E4 aggregation
    Anthony Legrand, Kateřina Amruz Černá, Sérgio M. Marques, Naina Verma, Jakub Kopko, Tereza Váňová, Madhumalar Subramanian, Aliaksandra Kursit, Jaroslav M. Bendl, Tomas Henek et al. · 2026 · Biomedicine & Pharmacotherapy
  97. Modeling Alzheimer’s Disease with APOE4 Neuron-Glial Brain Assembloids Reveals IGFBPs as Therapeutic Targets
    Eliana Sherman, Kevin Qiu, Rebecca Roberts, Lucille Shichman, Sihan Li, Huayu Sun, Lucie Ide, Allison Tucker, Seonjoo Lee, Weronika Gniadzik et al. · 2025 · SSRN Electronic Journal
  98. Additional file 3 of Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination
    Wang, Na, Wang, Minghui, Suren Jeevaratnam, Cassandra L. Rosenberg, Tadafumi C. Ikezu, Francis Shue, Sydney V. Doss, Alla Alnobani, Yuka A. Martens, Melissa C. Wren et al. · 2022 · Figshare
  99. Additional file 4 of Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination
    Wang, Na, Wang, Minghui, Suren Jeevaratnam, Cassandra L. Rosenberg, Tadafumi C. Ikezu, Francis Shue, Sydney V. Doss, Alla Alnobani, Yuka A. Martens, Melissa C. Wren et al. · 2022 · Figshare
  100. Additional file 5 of Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination
    Wang, Na, Wang, Minghui, Suren Jeevaratnam, Cassandra L. Rosenberg, Tadafumi C. Ikezu, Francis Shue, Sydney V. Doss, Alla Alnobani, Yuka A. Martens, Melissa C. Wren et al. · 2022 · Figshare